Cipla inks pacts to invest in iCaltech Innovations
Mumbai: Cipla Limited has announced that it has signed definitive agreements for investment in Optionally Convertible Preference Shares of iCaltech Innovations Private Limited, subject to completion of certain conditions.
iCaltech is engaged in the design, development, and commercialisation of diagnostic medical equipment and apparatus, with a core focus on respiratory care.
"Strategic partnerships remain central to Cipla’s innovation engine, as the company continues to expand its digital, devices and diagnostics offerings and build on its legacy of lung leadership," Cipla stated in a release.
iCaltech is a Bangalore based ISO 13485 certified Medical Devices Company. iCaltech conceptualises, develops, manufactures and markets Regulatory approved Medical Diagnostic Products. iCaltech conceptualises, develops, manufactures and markets Regulatory approved Medical Diagnostic Products.
Read also: Cipla Gets CDSCO Panel Nod To BE Study, Phase III Trial of Semaglutide for Weight Management
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.